Congfen Li

1.1k total citations
10 papers, 358 citations indexed

About

Congfen Li is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Congfen Li has authored 10 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Congfen Li's work include Cancer, Hypoxia, and Metabolism (2 papers), Liver physiology and pathology (2 papers) and Brain Metastases and Treatment (2 papers). Congfen Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Liver physiology and pathology (2 papers) and Brain Metastases and Treatment (2 papers). Congfen Li collaborates with scholars based in United States, United Kingdom and France. Congfen Li's co-authors include Priti S. Hegde, Thomas Sandmann, Olivier Chinot, Josep Garcia, Heidi Phillips, Wolfgang Wick, Carlos Bais, Ryo Nishikawa, Timothy F. Cloughesy and Lauren E. Abrey and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Congfen Li

10 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Congfen Li United States	6	197	147	113	87	69	10	358
Lotte Hiddingh United States	8	97 0.5×	214 1.5×	109 1.0×	203 2.3×	88 1.3×	9	523
Donna Carter United States	6	116 0.6×	246 1.7×	57 0.5×	199 2.3×	107 1.6×	7	408
Luke B. Fletcher United States	8	71 0.4×	168 1.1×	51 0.5×	64 0.7×	39 0.6×	16	328
Krister J. Barkovich United States	9	165 0.8×	252 1.7×	53 0.5×	152 1.7×	100 1.4×	13	440
Carlos R. Gil Del Alcazar United States	7	91 0.5×	247 1.7×	109 1.0×	205 2.4×	80 1.2×	9	440
Nguyen Tan United States	4	67 0.3×	343 2.3×	38 0.3×	179 2.1×	34 0.5×	7	460
Mark T. J. van Bussel Netherlands	8	96 0.5×	119 0.8×	52 0.5×	182 2.1×	165 2.4×	11	344
Amy Camuso United States	9	114 0.6×	113 0.8×	26 0.2×	163 1.9×	72 1.0×	12	402
Sujata Chakraborty United States	10	146 0.7×	286 1.9×	39 0.3×	94 1.1×	15 0.2×	17	541
Su-Ning Huang China	13	34 0.2×	280 1.9×	244 2.2×	74 0.9×	53 0.8×	22	433

Countries citing papers authored by Congfen Li

Since Specialization

Citations

This map shows the geographic impact of Congfen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congfen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congfen Li more than expected).

Fields of papers citing papers by Congfen Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congfen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congfen Li. The network helps show where Congfen Li may publish in the future.

Co-authorship network of co-authors of Congfen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Congfen Li. A scholar is included among the top collaborators of Congfen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congfen Li. Congfen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Daemen, Anneleen, Thomas Sandmann, Congfen Li, et al.. (2021). Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B. PLoS ONE. 16(12). e0262198–e0262198. 4 indexed citations

Yuen, Kobe, Lifen Liu, Congfen Li, et al.. (2020). Abstract 2000: Systemic and tumor associated IL-8 correlates with resistance to PD-L1 blockade. Cancer Research. 80(16_Supplement). 2000–2000. 1 indexed citations

Yuen, Kobe, Congfen Li, Deepali Rishipathak, et al.. (2019). Abstract 2676: Associations of peripheral biomarkers to outcomes to anti-PD-L1 immune checkpoint blockade in metastatic urothelial cancer. 2676–2676. 1 indexed citations

Sandmann, Thomas, Richard Bourgon, Josep Garcia, et al.. (2015). Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. Journal of Clinical Oncology. 33(25). 2735–2744. 208 indexed citations

Phillips, Heidi, Thomas Sandmann, Congfen Li, et al.. (2014). Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB]).. Journal of Clinical Oncology. 32(15_suppl). 2001–2001. 16 indexed citations

Penuel, Elicia, Congfen Li, Luciana Burton, et al.. (2013). HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors. Molecular Cancer Therapeutics. 12(6). 1122–1130. 20 indexed citations

Li, Congfen, Chikara Takahashi, Mahrukh Huseni, et al.. (2013). Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma. Journal of Translational Medicine. 11(1). 76–76. 8 indexed citations

Wong, Harvey, Laurent Vernillet, Amy Peterson, et al.. (2012). Bridging the Gap between Preclinical and Clinical Studies Using Pharmacokinetic–Pharmacodynamic Modeling: An Analysis of GDC-0973, a MEK Inhibitor. Clinical Cancer Research. 18(11). 3090–3099. 65 indexed citations

Li, Congfen, Ihsan Nijem, Premal H. Patel, et al.. (2010). Abstract 1670: Circulating biomarkers of MetMAb activity in a phase Ia dose escalating clinical trial. Cancer Research. 70(8_Supplement). 1670–1670. 1 indexed citations

10.

Chu, Peter C., Jun Wu, Xiang Liao, et al.. (2004). A Novel Role for p21-Activated Protein Kinase 2 in T Cell Activation. The Journal of Immunology. 172(12). 7324–7334. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact